Accelerate Start-up for Oncology Clinical Trials through Centralized Ethics Review
The strong demand for optimised oncology clinical trials has led Canadian provinces to implement centralised ethics review. Granted many of these provincial ethics…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…
Centralized Ethics Review for Oncology Trials in Canada – An interview with Janet Manzo, Executive Director, Ontario Cancer Research Ethics Board
In this interview Janet Manzo, Executive Director of the Ontario Cancer Research Ethics Board, discusses the development of a province-wide…
Why Canada is well suited for YOUR oncology clinical trials
To make it to the winner’s circle in this industry, you must know your strengths and leverage them to maximize…
FAQs – Oncology Clinical Research In Canada
At every industry event, from ASCO to DIA to ASH, I meet with senior executives from oncology drug developers looking to mitigate…
Quality, Speed & Performance – Keys to Canada’s Future – Interview with Karen Arts of the Ontario Institute for Cancer Research
Canada boasts several centers of excellence with a group of internationally renowned investigators that are at the forefront of oncology…
Benefits of Data Analytics in Oncology Clinical Research – Interview with Steve Sweeney
With the volume of medical data doubling every 5 years, the challenge has now become how to derive actionable insights…
Patients are the KEY Stakeholders in Clinical Trials
Last week I had the pleasure of sitting down for lunch with Sandra Gazel (@sgazel). Sandra is one the most…